{"id":{"repo_id":"mit","oai_identifier":"oai:dspace.mit.edu:1721.1/151634"},"canonical_url":"https://search.dev.ndltd.org/etd/mit/oai:dspace.mit.edu:1721.1/151634","repository":{"repo_id":"mit","name":"MIT","base_url":"https://dspace.mit.edu/oai/request"},"display":{"title":"Interpretable Modeling of Immunotherapy Response Factors","abstract":"Immunotherapy, which treats cancer by either stimulating or suppressing the immune system, has been extraordinarily effective for some cancers, such as breast cancer and B-cell lymphoma. A type of immunotherapy, checkpoint inhibitors work by blocking the ability of cancer cells to evade immune system detection. However, not all patients respond to checkpoint inhibitors, even those with the same tumor types, and the complexity of biological networks and diversity of patients makes it difficult for clinicians to understand why a patient does not respond to treatment. This thesis integrates RNA and whole-exome seqeuencing (WES) data into an interpretable machine learning model and investigates genetic factors that may separate responders from nonresponders. We discovered that both data types contribute to response separation and that certain gene sets may be especially important factors for predicting response. Further analysis to elucidate how much individual genes contribute to significant gene sets and response needs to be performed.","abstract_html":"Immunotherapy, which treats cancer by either stimulating or suppressing the immune system, has been extraordinarily effective for some cancers, such as breast cancer and B-cell lymphoma. A type of immunotherapy, checkpoint inhibitors work by blocking the ability of cancer cells to evade immune system detection. However, not all patients respond to checkpoint inhibitors, even those with the same tumor types, and the complexity of biological networks and diversity of patients makes it difficult for clinicians to understand why a patient does not respond to treatment. This thesis integrates RNA and whole-exome seqeuencing (WES) data into an interpretable machine learning model and investigates genetic factors that may separate responders from nonresponders. We discovered that both data types contribute to response separation and that certain gene sets may be especially important factors for predicting response. Further analysis to elucidate how much individual genes contribute to significant gene sets and response needs to be performed.","abstract_has_math":false,"creators":["Ting, Britney A."],"institution":"Massachusetts Institute of Technology","degree_name":"Master","degree_level":null,"degree_discipline":null,"degree_department":"Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science","school":null,"contributors":[],"advisors":["Fraenkel, Ernest"],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023-06","date_published":"2023-06","updated_at":"2026-07-22T22:21:42Z","subjects":[],"languages":[],"rights":["In Copyright - Educational Use Permitted","Copyright retained by author(s)"],"rights_urls":["https://rightsstatements.org/page/InC-EDU/1.0/"],"identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/1721.1/151634","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Fraenkel, Ernest"]},{"key":"dc:contributor.department","label":"Department","values":["Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science"]},{"key":"dc:creator","label":"Author","values":["Ting, Britney A."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2023-07-31T19:54:38Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2023-07-31T19:54:38Z"]},{"key":"dc:date.issued","label":"Date","values":["2023-06"]},{"key":"dc:publisher","label":"Institution","values":["Massachusetts Institute of Technology"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master","Master of Engineering in Electrical Engineering and Computer Science"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:rights","label":"Dc Rights","values":["In Copyright - Educational Use Permitted","Copyright retained by author(s)"]},{"key":"dc:rights.uri","label":"Rights URI","values":["https://rightsstatements.org/page/InC-EDU/1.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/1721.1/151634"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Immunotherapy, which treats cancer by either stimulating or suppressing the immune system, has been extraordinarily effective for some cancers, such as breast cancer and B-cell lymphoma. A type of immunotherapy, checkpoint inhibitors work by blocking the ability of cancer cells to evade immune system detection. However, not all patients respond to checkpoint inhibitors, even those with the same tumor types, and the complexity of biological networks and diversity of patients makes it difficult for clinicians to understand why a patient does not respond to treatment. This thesis integrates RNA and whole-exome seqeuencing (WES) data into an interpretable machine learning model and investigates genetic factors that may separate responders from nonresponders. We discovered that both data types contribute to response separation and that certain gene sets may be especially important factors for predicting response. Further analysis to elucidate how much individual genes contribute to significant gene sets and response needs to be performed."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["M.Eng."]},{"key":"dc:title","label":"Title","values":["Interpretable Modeling of Immunotherapy Response Factors"]}]}],"canonical_facts":{"dc:contributor.advisor":["Fraenkel, Ernest"],"dc:contributor.department":["Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science"],"dc:creator":["Ting, Britney A."],"dc:date.accessioned":["2023-07-31T19:54:38Z"],"dc:date.available":["2023-07-31T19:54:38Z"],"dc:date.issued":["2023-06"],"dc:description.abstract":["Immunotherapy, which treats cancer by either stimulating or suppressing the immune system, has been extraordinarily effective for some cancers, such as breast cancer and B-cell lymphoma. A type of immunotherapy, checkpoint inhibitors work by blocking the ability of cancer cells to evade immune system detection. However, not all patients respond to checkpoint inhibitors, even those with the same tumor types, and the complexity of biological networks and diversity of patients makes it difficult for clinicians to understand why a patient does not respond to treatment. This thesis integrates RNA and whole-exome seqeuencing (WES) data into an interpretable machine learning model and investigates genetic factors that may separate responders from nonresponders. We discovered that both data types contribute to response separation and that certain gene sets may be especially important factors for predicting response. Further analysis to elucidate how much individual genes contribute to significant gene sets and response needs to be performed."],"dc:description.degree":["M.Eng."],"dc:identifier.uri":["https://hdl.handle.net/1721.1/151634"],"dc:publisher":["Massachusetts Institute of Technology"],"dc:rights":["In Copyright - Educational Use Permitted","Copyright retained by author(s)"],"dc:rights.uri":["https://rightsstatements.org/page/InC-EDU/1.0/"],"dc:title":["Interpretable Modeling of Immunotherapy Response Factors"],"dc:type":["Thesis"],"thesis:degree_name":["Master","Master of Engineering in Electrical Engineering and Computer Science"]},"updated_at":"2026-07-22T22:21:42Z"}